Education
About Us
Working with TipRanks
Follow Us
Bios Equity COF, LP Insider Profile
4 Followers
Bios Equity COF, LP, Director, Ten Percent Owner at Actuate Therapeutics, Inc., holds 10.20M shares in Actuate Therapeutics, Inc. (Ticker: ACTU). Most recently, Bios Equity COF, LP Bought $71,428 shares of Actuate Therapeutics, Inc. on Jun 30, 2025 for an estimated value of 500.00K.
Bios Equity COF, LP has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Bios Equity COF, LP's holdings
Insider Roles
Director, Ten Percent Owner
Roles that Bios Equity COF, LP holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Bios Equity COF, LP
Bios Equity COF, LP's Trading History
List of latest transactions for each holding click on a transaction to see Bios Equity COF, LP's performance on stock
You May Also Like
Bios Equity COF, LP insider profile FAQ
What is the percentage of profitable transactions made by Bios Equity COF, LP?
The percentage of profitable transactions made by Bios Equity COF, LP is ―.
What is the average return per transaction made by Bios Equity COF, LP?
The average return per transaction made by Bios Equity COF, LP is ―.
What stocks does Bios Equity COF, LP hold?
Bios Equity COF, LP holds: ACTU stocks.
What was Bios Equity COF, LP’s latest transaction?
Bios Equity COF, LP latest transaction was an Informative Buy of $500.00K.
What was Bios Equity COF, LP's most profitable transaction?
Bios Equity COF, LP’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Bios Equity COF, LP's role in Actuate Therapeutics, Inc.?
Bios Equity COF, LP's role in Actuate Therapeutics, Inc. is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.